Skip to content

Clinical trials

Terminated Phase 1/2 Neuroblastoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuroblastoma Phase: Phase 1/2 Status: Terminated Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20112
20141
20181
20191
20202
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Giselle Sholler2
Bayer1
Bristol-Myers Squibb1
City of Hope Medical Center1
Clarity Pharmaceuticals Ltd1
Columbia University1
Hoffmann-La Roche1
University of California, San Francisco1
Y-mAbs Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuroblastoma10
Lymphoma4
Medulloblastoma3
Osteosarcoma3
Recurrence3
Leukemia2
Rhabdomyosarcoma2
Sarcoma, Ewing2
Anemia1
Astrocytoma1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.